サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1315699

尿路感染症検査市場：タイプ、検査、エンドユーザー別-2023-2030年の世界予測

Urinary Tract Infection Testing Market by Type, Test, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
尿路感染症検査市場：タイプ、検査、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

尿路感染症検査の世界市場は大きく成長し、2023年には5億7,159万米ドル、CAGR 10.67%と予測され、2030年には11億6,786万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の尿路感染症検査市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.尿路感染症検査の世界市場規模および予測は？

2.予測期間中、世界の尿路感染症検査市場を形成するCOVID-19の阻害要因と影響は？

3.尿路感染症検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.尿路感染症検査の世界市場における競争戦略は？

5.尿路感染症検査の世界市場における技術動向と規制の枠組みは？

6.尿路感染症検査の世界市場における主要ベンダーの市場シェアは？

7.尿路感染症検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 老人と女性の間で尿路感染症の発生率が増加
      • 糖尿病と腎臓結石の有病率
      • 迅速な診断を増やすための政府による有利な投資
    • 抑制要因
      • 製品のリコールと人々の認識不足
    • 機会
      • 配合剤の上市の増加
      • 新しい画像技術や検査装置の開発
    • 課題
      • 厳しい規制要件
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 尿路感染症検査市場：タイプ別

  • 膀胱炎
  • 腎盂腎炎
  • 尿道炎
  • 膣炎

第7章 尿路感染症検査市場テスト別

  • 膀胱鏡検査尿路感染症検査
  • 腎臓と膀胱の超音波検査尿路感染症検査
  • 実験室試験
  • 臨床検査以外の検査
  • 核スキャン尿路感染症検査
  • 感受性尿路感染症検査
  • 尿検査尿路感染症検査
  • 尿培養尿路感染症検査
  • 排尿時膀胱尿道造影図（VCUG）尿路感染症検査

第8章 尿路感染症検査市場：最終用途別

  • アカウンタブル・ケア組織
  • 一般開業医
  • 病院の救急部門
  • 病院検査室
  • リファレンスラボ
  • 緊急処置
  • 泌尿器科医
  • 泌尿器科医

第9章 南北アメリカの尿路感染症検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の尿路感染症検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの尿路感染症検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2022 VS 2030 (%)
  • FIGURE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
  • FIGURE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTOSCOPY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY KIDNEY & BLADDER ULTRASOUND URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NON-LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NUCLEAR SCANS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURE URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VOIDING CYSTOURETHROGRAM (VCUG) URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. URINARY TRACT INFECTION TESTING MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. URINARY TRACT INFECTION TESTING MARKET SIZE, BY GENERAL PRACTITIONERS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URGENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROGYNECOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROLOGISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 87. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 112. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 118. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 124. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 130. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 142. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 156. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 157. URINARY TRACT INFECTION TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-7C50F27396FF

The Global Urinary Tract Infection Testing Market is forecasted to grow significantly, with a projected USD 571.59 million in 2023 at a CAGR of 10.67% and expected to reach a staggering USD 1,167.86 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Urinary Tract Infection Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Urinary Tract Infection Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Cystitis, Pyelonephritis, Urethritis, and Vaginitis. The Pyelonephritis is projected to witness significant market share during forecast period.

Based on Test, market is studied across Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test, Non-Laboratory Test, Nuclear Scans Urinary Tract Infection Testing, Susceptibility Urinary Tract Infection Testing, Urinalysis Urinary Tract Infection Testing, Urine Culture Urinary Tract Infection Testing, and Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing. The Nuclear Scans Urinary Tract Infection Testing is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Accountable Care Organizations, General Practitioners, Hospital Emergency Departments, Hospital Laboratories, Reference Laboratories, Urgent Care, Urogynecologists, and Urologists. The Urgent Care is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Urinary Tract Infection Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Urinary Tract Infection Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urinary Tract Infection Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urinary Tract Infection Testing Market?

4. What is the competitive strategic window for opportunities in the Global Urinary Tract Infection Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Urinary Tract Infection Testing Market?

6. What is the market share of the leading vendors in the Global Urinary Tract Infection Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Urinary Tract Infection Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Urinary Tract Infection Testing Market, by Type, 2022 vs 2030
  • 4.3. Urinary Tract Infection Testing Market, by Test, 2022 vs 2030
  • 4.4. Urinary Tract Infection Testing Market, by End-Use, 2022 vs 2030
  • 4.5. Urinary Tract Infection Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of urinary tract infections among geriartic and women
      • 5.1.1.2. Prevalence of diabetes and kidney stones
      • 5.1.1.3. Favorable investments by the government to increase rapid diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and lack of awareness among the people
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing launch of combination drugs
      • 5.1.3.2. Development of new imaging technologies and testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Urinary Tract Infection Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Cystitis
  • 6.3. Pyelonephritis
  • 6.4. Urethritis
  • 6.5. Vaginitis

7. Urinary Tract Infection Testing Market, by Test

  • 7.1. Introduction
  • 7.2. Cystoscopy Urinary Tract Infection Testing
  • 7.3. Kidney & Bladder Ultrasound Urinary Tract Infection Testing
  • 7.4. Laboratory Test
  • 7.5. Non-Laboratory Test
  • 7.6. Nuclear Scans Urinary Tract Infection Testing
  • 7.7. Susceptibility Urinary Tract Infection Testing
  • 7.8. Urinalysis Urinary Tract Infection Testing
  • 7.9. Urine Culture Urinary Tract Infection Testing
  • 7.10. Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing

8. Urinary Tract Infection Testing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Accountable Care Organizations
  • 8.3. General Practitioners
  • 8.4. Hospital Emergency Departments
  • 8.5. Hospital Laboratories
  • 8.6. Reference Laboratories
  • 8.7. Urgent Care
  • 8.8. Urogynecologists
  • 8.9. Urologists

9. Americas Urinary Tract Infection Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Urinary Tract Infection Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Urinary Tract Infection Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing